A randomized controlled Phase II trial of vinorelbine plus capecitabine versus docetaxel plus capecitabine in anthracycline-pretreated women with metastatic breast cancer.
Background: Previous studies have shown that vinorelbine/capecitabine (NX) and docetaxel/capecitabine (TX) chemotherapy has a certain effect in advanced breast cancer. However, there are few clinical studies directly comparing TX and NX regimen chemotherapy, especially in patients with advanced brea...
| Publicado en: | Journal of Cancer Research & Therapeutics Vol. 16; no. 5; pp. 1069 - 1077 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Wolters Kluwer India Pvt Ltd
Oct2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |